Does Probe's Eye Subthalamic Nucleus Length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?

Kocabicak E., Aygun D., Ozaydin I., Jahanshahi A., Tan S. K. H., Onar M., ...Daha Fazla

TURKISH NEUROSURGERY, cilt.23, sa.5, ss.658-665, 2013 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.5137/1019-5149.jtn.8328-13.0
  • Dergi Adı: TURKISH NEUROSURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.658-665
  • Anahtar Kelimeler: Parkinson's disease, Subthalamic nucleus, Microelectrode recording, Magnetic resonance imaging, Deep brain stimulation, SAFETY, RISK
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

AIM: Subthalamic nucleus (STN) deep brain stimulation (DBS) has become a well-accepted treatment for patients with advanced Parkinson's disease (PD). During surgical planning for DBS, the length of the STN is taken into account and verified during microelectrode recording (MER) intraoperatively. Here, we addressed the question to which extent the length of the STN measured with the 12 weighted MRI in the probe's eye view corresponded with the intraoperatively determined length of the STN with MER.